Reproducción y fertilidad humana: Aspectos biomédicos de la familia de las lipocalinas. Biología, patobiología y bioclínica

Reproduction and human fertility: Biomedical aspects of the lipocalin family. Biology, pathobiology and bioclínica

1. Flower DR. The lipocalin protein family: a role in cell regulation. FEBS Lett 1994; 354(1): 7-11.

2. PubMed [base de datos en Internet]. Bethesda, Maryland: National Library of Medicine; 1966- [citado 15 Jul 2008]. Disponible en: http://www.ncbi.nlm.nih.gov/PubMed/

3. EMBASE [base de datos en Internet]. Holanda: Excerpta Medica-Elsevier; 1974- [citado 15 Jul 2008]. Disponible en: http://www.embase.com

4. OMIM [base de datos en Internet]. Baltimore: Johns Hopkins University; 1966- [citado 15 Jul 2008]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/dispomim

5. HUGO [base de datos en Internet]. Bethesda, Maryland: National Library of Medicine, Celera Genomics and the Sanger Center; 1989- [citado 15 Jul 2008]. Disponible en: http://www.hugo-international.org/index.html

6. García GA, Clavijo D, Mejía OR, et al. Aspectos biomédicos de la familia de las lipocalinas. Univ. Méd. 2007; 48(2): 118-28.

7. García GA, García A. Aspectos biomédicos de las inmunocalinas en la especie humana. Univ. Méd. 2008; 49(1): 77-96.

8. Flower DR. Experimentally determined lipocalin structures. Biochim Biophys Acta. 2000 Oct 18;1482(1-2):46-56.

9. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 2000 Oct 18;1482(1-2):9-24.

10. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996; 318:1-14..

11. Sivaprasadarao A, Boudjelal M, Findlay JB. Lipocalin structure and function. Biochem Soc Trans. 1993; 21: 619-22.

12. Hayaishi O. Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D(2) system. J Appl Physiol. 2002; 92:863-8.

13. Herlong JL, Scott TR. Positioning prostanoids of the D and J series in the immunopathogenic scheme. Immunol Lett. 2006;102:121-31.

14. Maesaka JK, Palaia T, Fishbane S et al. Contribution of Prostanglandin D2 synthase to progression of renal failure and dialysis dementia. Semin Nephrol. 2002; 22: 407-14.

15. Iwa Y, Taba Y, Miyagi M, et al. Physiology and pharmacology of the prostaglandin J2 family. Nippon Yakurigaku Zasshi. 2004;123(1): 34-40.

16. Pinzar E, Kanaoka Y, Inui T, et al. Prostaglandin D synthase gene is involved in the regulation of nonrapid eye movement sleep. Proc Nat Acad Sci USA. 2000; 97: 4903-07.

17. Sasaguri T, Miwa Y. Prostaglandin J2 family and the cardiovascular system. Curr Vasc Pharmacol. 2004; 2:103-14.

18. Tanaka T, Urade Y, Kimura H et al. Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter. J Biol Chem 1997; 272: 15789-95.

19. Urade Y, Hayaishi O. Prostaglandin D2 and sleep regulation. Biochim Biophys Acta. 1999; 1436: 606- 15.

20. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm. 2000; 58:89-120.

21. Urade Y, Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta. 2000;1482: 259-71.

22. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat. 2002; 68-69:375-82.

23. García GA, Hernández S, Mejía OR, et al. Biología y patobiología humanas del complejo de absorción y transporte epitelial MegaCUBAM. Rev Fac Med Uni- versidad Militar Nueva Granada. 2007; 15(1): 94-104.

24. Faber K, Hvidberg V, Moestrup SK, et al. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol Endocrinol. 2006;20:212-8.

25. Flower DR. Beyond the superfamily: the lipocalin receptors. Biochim Biophys Acta. 2000;1482: 327-36.

26. Hvidberg V, Jacobsen C, Strong RK, et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005; 579:773-7.

27. Wojnar P, Lechner M, Mershak P et al. Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display. J Biol Chem 2001; 276: 20206-20212.

28. Wojnar P, Lechner M, Redl B. Antisense down-regulation of lipocalin-interacting membrane receptor expression inhibits cellular internalization of lipocalin-1 in human NT2 cells. J Biol Chem. 2003; 278: 16209-15.

29. Leone MG, Haq HA, Saso L. Lipocalin type prostaglandin D-synthase: which role in male fertility?. Contraception. 2002; 65:293-5.

30. Saito S, Tsuda H, Michimata T. Prostaglandin D2 and reproduction. Am J Reprod Immunol. 2002; 47: 295-302.

31. Wilhelm D, Hiramatsu R, Mizusaki H, et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. J Biol Chem 2007; 282:10553-60.

32. Helliwell RJ, Keelan JA, Marvin KW, et al. Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. J Clin Endocrinol Metab. 2006; 91:597-606.

33. Alttunen M, Kamarainen M, Koistinen H. Glycodelin: a reproduction-related lipocalin. Biochim Biophys Acta 2000;1482:149-56.

34. Kontopidis G, Holt C, Sawyer L. Invited review: betalactoglobulin: binding properties, structure, and function. J Dairy Sci. 2004;87:785-96.

35. Mandelin E, Lassus H, Seppala M et al. Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res. 2003;63: 6258-64.

36. Morris HR, Dell A, Easton RL et al. Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem. 1996; 271: 32159-67.

37. Seppälä M, Taylor RN, Koistinen H et al. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 2002; 23: 401-30.

38. Song M, Ramaswamy S, Ramachandran S, et al. Angiogenic role for glycodelin in tumorigenesis. Proc Nat Acad Sci USA. 2001; 98: 9265-70.

39. Yaniv E, Borovsky Z, Mishan-Eisenberg G, et al. Placental protein 14 regulates selective B cell responses. Cell Immunol. 2003; 222:156-63.

40. Dong M, Ding G, Zhou J et al. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules—a proteomic analysis. Cell Physiol Biochem. 2008;21:463-72.

41. Rawn SM, Cross JC. The evolution, regulation, and function of placenta-specific genes. Annu Rev Cell Dev Biol. 2008;24:159-81.

42. Arck P, Hansen PJ, Mulac Jericevic B, et al. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol. 2007; 58: 268-79.

43. Fujikura T, Mukai M. Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am J Obstet Gynecol. 2007;196:361.

44. Athanasas-Platsis S, Somodevilla-Torres MJ, et al. Investigation of the immunocompetent cells that bind early pregnancy factor and preliminary studies of the early pregnancy factor target molecule. Immunol Cell Biol. 2004; 82: 361-9.

45. Skornicka EL, Kiyatkina N, Weber MC, et al. Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production. Cell Immunol. 2004; 232: 144-56.

46. González A, Varo N, Alegre E, Díaz A, et al. Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach. Adv Clin Chem. 2008; 45: 155-97.

47. Kuroki K, Maenaka K. Immune modulation of HLA- G dimer in maternal-fetal interface. Eur J Immunol. 2007; 37:1727-9.

48. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy?. Semin Immunopathol. 2007; 29: 95-113.

49. Uemura Y, Suzuki M, Liu TY, et al. Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy. Int Immunol. 2008; 20:405-12.

50. Van den Heuvel MJ, Hatta K, Peralta CG, et al. CD56+ cells are recruited to the uterus in two waves: at ovulation and during the first 2 weeks after missed menses. Am J Reprod Immunol. 2008; 59:90-8.

51. Saito S, Shima T, Nakashima A, et al. What is the role of regulatory T cells in the success of implantation and early pregnancy?. J Assist Reprod Genet. 2007; 24:379-86.

52. LinksKämmerer U. Antigen-presenting cells in the decidua. Chem Immunol Allergy. 2005; 89:96-104.

53. Ha CT, Waterhouse R, Wessells J, et al. Binding of pregnancy-specific glycoprotein 17 to CD9 on macrophages induces secretion of IL-10, IL-6, PGE2, and TGF-beta1. J Leukoc Biol. 2005; 77:948-57.

54. Sharony R, Zadik I, Parvari R. Congenital deficiency of alpha feto-protein. Eur J Hum Genet. 2004; 12:871- 4.

55. Sarafana S, Coelho R, Neves A, et al. Gestational immunology. Acta Med Port. 2007; 20: 355-8.

56. Linksvon Rango U. Fetal tolerance in human pregnancy—a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008; 115(1):21-32.

57. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J. 1992; 6:3345-53.

58. Elangovan N, Lee YC, Tzeng WF et al. Delivery of ferric ion to mouse spermatozoa is mediated by lipocalin internalization. Biochem Biophys Res Commun. 2004; 319: 1096-1104.

59. Misra UK, Gonzalez-Gronow M, Gawdi G, et al. A novel receptor function for the heat shock protein Grp78: silencing of Grp78 gene expression attenuates alpha2M*-induced signalling. Cell Signal. 2004; 16:929-38.

60. Misra UK, Gonzalez-Gronow M, Gawdi G, et al. The role of MTJ-1 in cell surface translocation of GRP78, a receptor for alpha 2-macroglobulin-dependent signaling. J Immunol. 2005; 174:2092-7.

61. Ryon J, Bendickson L, Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J. 2002; 367(Pt 1):271-7.

62. Lee YC, Liao C Jr, Li PT, et al. Mouse lipocalin as an enhancer of spermatozoa motility. Mol Biol Rep. 2003; 30:165-72.

63. Lee YC, Elangovan N, Tzeng WF et al. Mouse uterine 24p3 protein as a suppressor of sperm acrosome reaction. Mol Biol Rep. 2005; 32: 237-45.

64. Fouchécourt S, Charpigny G, Reinaud P, et al. Mammalian lipocalin-type prostaglandin D2 synthase in the fluids of the male genital tract: putative biochemical and physiological functions. Biol Reprod. 2002; 66: 458-67.

65. Sundaram M, van Aalten DM, Findlay JB et al. The transfer of transthyretin and receptor-binding properties from the plasma retinol-binding protein to the epididymal retinoic acid-binding protein. Biochem J. 2002; 362: 265-71.

66. Suzuki K, Lareyre JJ, Sanchez D et al. Molecular evolution of epididymal lipocalin genes localized on mouse chromosome 2. Gene. 2004; 339:49-59.

67. Yu X, Gupta A, Wang Y, et al. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Ann N Y Acad Sci. 2005; 1061:77-93.

68. Suzuki K, Yu X, Chaurand P et al. Epididymis-specific promoter-driven gene targeting: A transcription factor which regulates epididymis-specific gene expression. Mol Cell Endocrinol 2006;250:184-9.

69. Suzuki K, Yu X, Chaurand P, Araki Y, et al. Epididymisspecific lipocalin promoters. Asian J Androl. 2007; 9:515-21.

70. Drevon CA. Fatty acids and expression of adipokines. Biochim Biophys Acta. 2005; 1740: 287-92.

71. Cho YM, Youn BS, Lee H, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2006; 29:2457-61.

72. Krzyzanowska K, Zemany L, Krugluger W, et al. Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes. Diabetologia. 2008; 51:1115-22.

73. Ueland T, Dalsoren T, Voldner N, et al. Retinol-binding protein-4 is not strongly associated with insulin sensitivity in normal pregnancies. Eur J Endocrinol. 2008; 159:49-54.

74. García GA, Gaitán A. Biología feromonal en la especie humana. Repert med cir. 2008; 17: 72-89.

75. McClintock MK. Menstrual synchrony and suppression. Nature. 1971; 229: 244-45.

76. McClintock MK. Estrous synchrony and its mediation by airborn chemical communication (Rattus norvegicus). Horm Behav.1978; 10: 264-76.

77. Graham CA, McGrew WC. Menstrual synchrony in female undergraduates living on a coeducational campus. Psychoneuroendocrinology. 1980; 5: 245-52.

78. Schmale H, Ahlers C, Blaker M et al. Perireceptor events in taste. Ciba Found Symp. 1993; 179:167-80.

79. Quadagno DM, Shubeita HE, Deck J, et al. Influence of male social contacts, exercise and all-female living conditions on the menstrual cycle. Psychoneuroendocrinology. 1981; 6: 239-44.

80. Zeng C, Spielman AI, Vowels BR, et al. A human axillary odorant is carried by apolipoprotein D. Proc Nat Acad Sci USA. 1996; 93: 6626-30.

81. Briand L, Eloit C, Nespoulous C, et al. Evidence of an odorant-binding protein in the human olfactory mucus: location, structural characterization, and odorantbinding properties. Biochemistry. 2000; 41: 7241-52.

82. Brennan PA. The vomeronasal system. Cell Mol Life Sci. 2001; 58: 546-55.

83. Duque Parra JE, Duque Parra CA. Nervio terminal: el par craneal cero. MedUNAB. 2006; 3: 246-9.

84. Mundy NI. Genetic basis of olfactory communication in primates. Am J Primatol. 2006; 68:559-67.

85. Cavaggioni A, Mucignat C, Tirindelli R. Pheromone signalling in the mouse: role of urinary proteins and vomeronasal organ. Arch Ital Biol. 1999;137:193-200.

86. Cavaggioni A, Mucignat-Caretta C. Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim Biophys Acta. 2000;1482: 218-28.

87. Beynon RJ, Hurst JL. Multiple roles of major urinary proteins in the house mouse, Mus domesticus. Biochem Soc Trans. 2003; 31:142-6.

88. Beynon RJ, Hurst JL. Urinary proteins and the modulation of chemical scents in mice and rats. Peptides 2004; 25:1553-63.

89. Briand L, Trotier D, Pernollet JC. Aphrodisin, an aphrodisiac lipocalin secreted in hamster vaginal secretions. Peptides. 2004; 25:1545-52.

90. Armstrong SD, Robertson DH, Cheetham SA, et al. Structural and functional differences in isoforms of mouse major urinary proteins: a male-specific protein that preferentially binds a male pheromone. Biochem J. 2005; 391(Pt 2):343-50.

91. Kristensen K, Wide-Swensson D, Schmidt C, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand. 2007; 86: 921-6.

92. Chen DY, Wang JJ, Huang YF, et al. Relationship between lipocalin-type prostaglandin D synthase and alpha-glucosidase in azoospermia seminal plasma. Clin Chim Acta. 2005; 354:69-76.

93. Heshmat SM, Mullen JB, Jarvi KA et al. Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia. J Urol. 2008; 179:1077-80.

94. Kim J, Yang P, Suraokar M, et al. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005; 65:6189-98.

95. Suzuki T, Hayashi S, Miki Y, et al. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Endocr Relat Cancer. 2006; 13:233-50.

96. Shiki Y, Shimoya K, Tokugawa Y, et al. Changes of lipocalin-type prostaglandin D synthase level during pregnancy. J Obstet Gynaecol Res. 2004; 30: 65-70.